<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063241/" ref="ordinalpos=117&amp;ncbi_uid=2848593&amp;link_uid=PMC3063241" image-link="/pmc/articles/PMC3063241/figure/pone-0018066-g004/" class="imagepopup">Figure 4. Log2 fold change of microarray estimated expression for genes from an investigated <span class="highlight" style="background-color:">pathway</span> are plotted as a cumulative distribution function (in red color) and compared with the corresponding cumulative distribution function for the rest of genes (i.e., not belonging to the investigated <span class="highlight" style="background-color:">pathway</span>, in blue color)..  From: Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma. </a></div><br /><div class="p4l_captionBody">A) P53 signaling pathway in USC vs. EAC-G3 comparison. The two cumulative distribution functions are significantly different (P = 4.5e-3) by the Kolmogorov-Smirnov test. B) P53 signaling pathway in USC vs. EAC-G1 comparison. C) PTEN signaling pathway in USC vs. EAC-G3 comparison. D) PTEN signaling pathway in USC vs. EAC-G1 comparison.</div></div>